DNA contamination in an RNA sample can be detrimental to the rRNA depletion or mRNA capture assay prior to RNASeq library prep. We currently use the Bioanalyzer for RNA QC but it is not satisfactory for determining DNA contamination, unless it is obvious high molecular weight DNA. Sometimes an RNA with a good RIN score will still fail rRNA depletion/mRNA capture because there is DNA contamination that was not detected by the Bioanalzyer. Are there other types of RNA QC assays that could help us better determine whether or not we have DNA contamination in our RNA samples?
Unconfigured Ad
Collapse
X
-
Thanks for your response. We are not sure what the downstream sequencing would look like if we performed library prep on one of the DNA contaminated samples. Since the Bioanalzyer profile looked odd, we stopped there and DNAsed the Total RNA and repeated rRNA depletion. I posted below, a rRNA depleted sample from Total RNA before and after DNAse treatment. The profile after DNAse treatment is what we normally see as a "good" profile. The profile in which the Total RNA was not DNase treated, was odd.Attached Files
Comment
-
-
I do not know how rRNA depleted RNA profile should look like, but double depletion is expensive and not a good idea. The best practice is to do DNase treatment on total RNA extract before any downstream application. Genomic DNA contamination will be seen as high molecular fragments on RNA Chip. In your before treatment Bioanalyser trace if the peak at 100-150 bp are DNA they will be washed away during library prep and less likely will end up in RNA-Seq library. Generally DNA contamination will show up as higher alignment of reads to intergenic regions.
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Today, 11:41 AM
|
0 responses
8 views
0 reactions
|
Last Post
by SEQadmin2
Today, 11:41 AM
|
||
|
Started by SEQadmin2, 07-20-2026, 11:10 AM
|
0 responses
21 views
0 reactions
|
Last Post
by SEQadmin2
07-20-2026, 11:10 AM
|
||
|
Started by SEQadmin2, 07-13-2026, 10:26 AM
|
0 responses
34 views
0 reactions
|
Last Post
by SEQadmin2
07-13-2026, 10:26 AM
|
||
|
Started by SEQadmin2, 07-09-2026, 10:04 AM
|
0 responses
44 views
0 reactions
|
Last Post
by SEQadmin2
07-09-2026, 10:04 AM
|
Comment